Gastrin I (human)

Gastrin I (human) is a naturally occurring peptide hormone composed of a specific sequence of amino acids, produced primarily in the G cells of the human stomach. This compound plays a pivotal role in the regulation of gastric acid secretion and gastrointestinal motility, making it an essential molecule for researchers investigating digestive physiology. Its unique structure allows for selective binding to gastrin receptors, facilitating detailed studies into receptor-ligand interactions and downstream signaling pathways. Due to its high biological relevance, Gastrin I (human) is widely utilized in a variety of laboratory settings, supporting both fundamental research and the development of innovative experimental models. Researchers value its stability and specificity, which contribute to reproducible results in a range of investigative contexts.

Gastrointestinal Physiology Research: Human Gastrin I is extensively employed in studies aiming to elucidate the mechanisms governing gastric acid secretion and digestive functions. By introducing this peptide into in vitro or ex vivo models, scientists can simulate physiological conditions and observe the responses of gastric parietal cells, enterochromaffin-like cells, and other relevant cell types. Such investigations provide critical insights into the regulation of acid production, mucosal protection, and the feedback loops that maintain gastrointestinal homeostasis. The ability to manipulate and monitor these processes with Gastrin I (human) enables researchers to dissect the intricate signaling networks underlying normal digestive physiology.

Receptor Binding and Signal Transduction Studies: The unique affinity of Gastrin I (human) for cholecystokinin-B/gastrin receptors makes it an indispensable tool for exploring receptor-ligand interactions and downstream signaling events. Utilizing this peptide in binding assays or signal transduction experiments allows for the characterization of receptor specificity, affinity, and activation profiles. These studies are fundamental in mapping the molecular pathways triggered by gastrin and related peptides, shedding light on the physiological and pathophysiological roles of these receptors. The information gathered from such research can inform the design of new molecules targeting the gastrin receptor pathway.

Tumor Biology and Cellular Proliferation: Gastrin I (human) is utilized in cancer biology research, particularly in the context of gastrointestinal and neuroendocrine tumors. By administering this peptide to cultured cell lines or tissue explants, investigators can study its effects on cellular proliferation, migration, and gene expression. These experiments help delineate the role of gastrin signaling in tumor growth and progression, offering valuable clues about the molecular drivers of oncogenesis in the gastrointestinal tract. Understanding these mechanisms is essential for identifying potential therapeutic targets and developing strategies to modulate abnormal cell growth.

Drug Discovery and Pharmacological Screening: Gastrin I (human) serves as a reference compound in drug discovery efforts focused on modulating gastric acid secretion or gastrin receptor activity. Researchers employ it in high-throughput screening assays to evaluate the efficacy and specificity of novel small molecules, peptides, or biologics designed to interact with the gastrin signaling pathway. This application supports the identification and optimization of candidate compounds with potential utility in managing acid-related disorders or other conditions involving aberrant gastrin activity. The consistent performance of Gastrin I (human) in such assays ensures reliable benchmarking during the early stages of pharmaceutical development.

Gastrointestinal Disease Modeling: The use of Gastrin I (human) extends to the creation of experimental models that mimic various gastrointestinal disorders, including hypergastrinemia, Zollinger-Ellison syndrome, and peptic ulcer disease. By administering this peptide in animal models or organoid cultures, researchers can reproduce disease-like states and investigate the underlying pathophysiological mechanisms. These models are invaluable for testing hypotheses about disease initiation and progression, as well as for evaluating the impact of potential therapeutic interventions. The ability to induce and study disease-relevant changes with Gastrin I (human) significantly advances our understanding of gastrointestinal pathologies and supports the development of innovative research tools.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active